Shahnaz Barat

Shahnaz Barat

Auto-generated profile, based on publicly available information

Shahnaz Barat

Obstetrics and Gynecology Infertility and Reproductive Health Research Center, Health Research Institute Babol Iran

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2015 in Human Reproduction
Verified
Journal Article
Open access
PDF file
MFMahbobeh Faramarzi
Mahbobeh Faramarzi
SYShala Yazdani
Shala Yazdani
SBShahnaz Barat
Shahnaz Barat
Does adding psychological intervention to medical therapy improve nausea/vomiting, psychological symptoms, and pregnancy distress in women with moderate nausea and vomiting of pregnancy (NVP)? Three weeks of medical therapy plus psychotherapy yielded statistically and clinically significant improvements in NVP-specific symptoms, anxiety/depression symptoms, and pregnancy distress, compared with medical therapy alone. Pregnancy with nausea/vomiting is associated with psychiatric morbidity. Evidence supports the exploration of psychosocial reactions in addition to biochemical markers related to NVP. This prospective, open-label, randomized, controlled, parallel-group study was performed at two obstetrics clinics in Iran. A total of 86 women, aged 18–40 years, between 6 and 12 weeks pregnant with moderate NVP, more than 5 years of education, and not currently practicing any relaxation techniques or undergoing any psychotherapy, were enrolled from June 2013 to November 2014. A total of 86 moderate NVP women were randomly allocated to either a control (medical therapy alone) or experimental (medical therapy plus psychotherapy) group. Block randomization was achieved using a paper list prepared by an investigator with no clinical involvement in the trial. The experimental group was given pyridoxine hydrochloride (40 mg daily) for 3 weeks, and also received intensive mindfulness-based cognitive therapy (MBCT) in eight individual sessions (50 min each) over 3 weeks. The control group was given pyridoxine hydrochloride (40 mg daily tablet) for 3 weeks alone. All participants completed the Rhodes index of nausea, vomiting and retching (RINVR), the hospital anxiety and depression scale (HADS), and the prenatal distress questionnaire (PDQ) at baseline, 3 weeks after baseline at the end of the study, and at a 1 month post-treatment follow-up. Linear mixed-effects models were used, in an intention-to-treat analysis. In the psychotherapy plus medical therapy group, the mean relative difference between baseline and post-treatment decreased for RINVR; nausea 8.2 (95% confidence interval (CI) 4.1, 10.2), vomiting 3.5 (95% CI 1.5, 5.8), and total RINVR 11.7 (95% CI 6.5, 16.5), for HADS; anxiety 5.1 (95% CI 3.2, 9.2), depression 3.5 (95% CI 2.4, 7.3), total HADS 7.2 (95% CI 4.4, 12.1), for PDQ; birth concerns 3.3 (95% CI 1.3, 9.1), body concerns 1.5 (95% CI 0.9, 5.1), relationship concerns 2.1 (95% CI 1.2, 5.9), and total PDQ 5.9 (95% CI 3.5, 10.6). At 1 month after treatment, the statistically significant improvement in RINVR, HADS and PDQ, as well as clinical improvement in severity of symptoms, persisted. Medical therapy plus psychotherapy also improved nausea/vomiting symptoms, psychological symptoms, and reduced pregnancy distress more than medical therapy alone, with an effect size of 0.42–0.72 over the trial period. The conclusions were limited to a small number of women with moderate NVP. It is unclear whether the difference between the outcomes in the different groups was related to MBCT alone, or to the extra time and attention paid to patients in the medical therapy plus psychotherapy. The participants in the study did not remain blind to the treatment and the outcome may only be representative of women with moderate NVP who have been referred to obstetrics clinics. These findings show that adding 3 weeks of psychological intervention to medical therapy may appear to produce positive therapeutic outcomes upon conclusion of treatment, and 1 month after treatment. This suggests that psychotherapy should be considered as an adjunctive treatment option for women with moderate NVP. In future studies, however, a group of patients who are receiving placebo psychotherapy along with medical treatment should be included. Furthermore, an economic evaluation of the addition of psychological intervention to standard medical therapy would be useful. The study was funded by Infertility and Reproductive Health Research Center of the Babol University of Medical Sciences. The authors have no conflicting interests. IRCT201304035931N2. 3 April 2013. 1 June 2013.

5 April 2013 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
FLFarideh Mohsenzadeh Ledari
Farideh Mohsenzadeh Ledari
SBShanaz Barat
Shanaz Barat
MDMouloud Agajani Delavar
Mouloud Agajani Delavar
SBSeyed Zahra Banihosini
Seyed Zahra Banihosini
SKSoriya Khafri
Soriya Khafri
Background: Gum chewing after cesarean section may stimulate bowel motility and decrease duration of postoperative ileus. Objectives: The current study assessed the effect of chewing sugar-free gum on the return of bowel function, where cesarean section had been performed in nulliparous women. Materials and Methods: In a randomized clinical trial, 60 patients, scheduled for cesarean section were randomly divided in to 2 groups gum-chewing group (n = 30) and control group (n = 30) postoperatively. The patients in the gum-chewing group postoperatively chewed sugar free gum 3 times daily each time for 1 hour until discharge. The patients' demographic characteristics, duration of surgery, mean hunger time, flatus and bowel motility were compared in the two groups. Results: There was no significant difference between the 2 groups regarding patient demographics, intraoperative, and postoperative care. In the gum-chewing and the control group there was a significant difference in the mean postoperative interval of the first bowel movement (20.89 ± 8.8 versus 27.93 ± 9.3 hours, P = 0.004), the first feeling of hunger (10.37 ± 6.0 versus 16.33 ± 9.3 hours, P = 0.005), the first passage of flatus (25.02 ± 5.8 versus 31.08 ± 9.7 hours, P = 0.003), and the first defecation (31.17 ± 5.3versus 40.08 ± 8.8 hours, P = 0.000) respectively, which were significantly shorter in the gum-chewing group compared to those of the control group. There were no major complications in either group. All patients in the gum-chewing group tolerated it without any major complications and side effects. Conclusions: The study results demonstrated that bowel motility after cesarean section in nulliparous women can be accelerated by gum chewing which is a useful, inexpensive and well-tolerated method for mothers in post-cesarean section. Keywords: Chewing Gum; Ileus; Cesarean Section; Flatulence; Randomized Controlled Trials as Topic

18 February 2022 in Health Science Reports
Verified
Journal Article
Open access
PDF file
AHAngela Hamidia
Angela Hamidia
FKFarzan Kheirkhah
Farzan Kheirkhah
MCMohammad Chehrazi
Mohammad Chehrazi
ZBZahra Basirat
Zahra Basirat
RGReza Ghadimi
Reza Ghadimi
MFMahbobeh Faramarzi
Mahbobeh Faramarzi
Purpose: This study investigated the optimal cutoff points of three psychological tools for screening psychiatric disorders in women with high‐risk pregnancy.Design and Methods: In this cross‐sectional study (N = 155), sensitivity/specificity of the Edinburgh Postnatal Depression Scale (EPDS), the Brief Symptom Inventory 53‐items (BSI‐53), and the BSI‐18 were computed with respect to having a psychiatric diagnosis based on the clinical interview.Results: The usual cutoffs (≥13 for EPDS, T‐score of 63 for BSI‐53) demonstrated poor diagnostic accuracy. The optimal thresholds were computed for EPDS cutoff of 6.5, GSI = 0.47 for BSI‐53, and GSI = 0.5 for BSI‐18.Practice Implications: The use of psychological tools among pregnant women with high‐risk pregnancy may need to be modified in order to accurately identify psychiatric disorders.

15 May 2020 in Oman Medical Journal
Verified
Journal Article
Open access
SBShahnaz Barat
Shahnaz Barat
SYShahla Yazdani
Shahla Yazdani
MFMahbobeh Faramarzi
Mahbobeh Faramarzi
SKSoraya Khafri
Soraya Khafri
MDMaryam Darvish
Maryam Darvish
NANesa Asnafi
Nesa Asnafi
Miscarriage is a common pregnancy complication causing substantial psychiatric complications. This study was designed to investigate whether the administration of brief supportive psychotherapy (BSP) is effective on the management of women with miscarriage when conducted in the first 24 hours of hospitalization in order to prevent symptoms of anxiety, depression, and grief at four-months post-miscarriage. We conducted a randomized clinical trial on 79 women with miscarriage hospitalized in Ayatollah Rohani teaching hospital. The women were randomly assigned into two groups (39 in the experimental group and 40 in the control group). All interventions were implemented for two study groups during the first 24 hours of hospitalization in a private room in the hospital. The experimental group received a two-hour BSP. The objective outcomes were assessed using Hospital Anxiety and Depression Scale and Perinatal Grief Scale (PGS), which has three subscales (active grief, difficulty coping, and despair) and were measured before the intervention and at four-months post-miscarriage. The results of pre-tests in the follow-up of the trial suggested that the participants who received BSP reported significant reductions in the mean scores of active grief (-34.2±9.7 vs. 28.1±-6.9), difficulty coping (27.1±6.4 vs. 23.3±4.3), despair (28.0±8.4 vs. 22.8±5.2), and total PGS (89.6±23.1 vs. 74.4±15.3), in contrast to participants in the control group who did not report such results. Further, the results of generalized estimating equations models revealed that brief supportive psychotherapy caused a significant decrease in the level of factors including active grief, difficulty coping, despair, total perinatal grief, anxiety symptoms, and depressive symptoms in subjects in the experimental group compared to those in the control group after miscarriage. Also, the frequency of anxiety symptoms (13.5% vs. 60.5%), depressive symptoms (32.4% vs. 71.1%), and grief symptoms (10.8% vs. 65.8%) was found to be significantly lower in the group receiving psychotherapy than in the control group at four-months follow-up. Administration of BSP session during the first 24 hours of hospitalization for women with miscarriage can be considered a reliable method to prevent anxiety symptoms, depression symptoms, and perinatal grief at four-months follow-up.

13 February 2023 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
SMSeyyedeh Mahboubeh Mirtabar
Seyyedeh Mahboubeh Mirtabar
ZPZeynab Pahlavan
Zeynab Pahlavan
SASajedeh Aligoltabar
Sajedeh Aligoltabar
SBShahnaz Barat
Shahnaz Barat
FNFatemeh Nasiri-Amiri
Fatemeh Nasiri-Amiri
MFMahbobeh Faramarzi
Mahbobeh Faramarzi
Background: Pregnant women with suspected fetal anomalies experience a great deal of stress following prenatal screening tests. The present study aimed to investigate women's worries about prenatal screening tests suspected of fetal anomalies. Methods: Through the use of qualitative content analysis, the reports of women whose prenatal screening tests were suspected of fetal anomalies were analyzed and the results were interpreted. The participants were selected from four public and private maternity care clinics of Babol, Iran, from December 2021 to January 2022, using targeted convenience sampling. Data were collected from 20 women aged 24 to 41 years old, who underwent prenatal screening tests and were suspected of fetal anomalies, using semi-structured face-to-face interviews. Results: The four main themes included the "causes of worries" (with sub-themes of challenge with spouse and relatives, medical diagnosis processes, previous unpleasant experiences, physical and mental problems, financial worries, and misinformation), "anxiety-coping styles" (with cognitive emotion-oriented, behavioral emotion-oriented, and problem-oriented sub-themes), "reactions to a possible diagnosis of anomaly" (with three sub-themes, namely concealment, extreme fear and worry, and denial), and "attribution of the cause of the anomaly" (with sub-themes of consanguine marriage, evil eyes, tendency to have a baby of a particular gender, a history of anomalies in the previous child, the spouse's medical illness, unplanned pregnancy, and high maternal anxiety). Conclusion: Women with suspected fetal anomalies experience a great deal of stress, the most important reason for which is the "physician’s uncertainty". "Sharing worries with relatives" was the most common style of coping with worries. Establishing emotional support and empathetic communication between midwives and physicians with pregnant women suspected of fetal anomalies were important ways to reduce their worries.

10 April 2014 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Closed access
ZBZ. Bouzari
Z. Bouzari
MJM. Javadiankutenai
M. Javadiankutenai
ADA. Darzi
A. Darzi
SBS. Barat
S. Barat
Objective: Preeclampsia is defined by the new onset of elevated blood pressure and protienuria after 20 weeks of gestation. Protienuria is one of the essential criteria for the clinical definition of preeclampsia. The authors investigated the predictive value of proteinuria in the outcome of pregnancies with preeclampsia. Materials and Methods: In this retrospective cohort study, they entered all pregnant women who were admitted with diagnosis of preeclampsia in Yahyanejad Hospital from 1998 to 2008. Patients’ data such as age, gestational age, level of 24-hour urine protein, liver enzyme, blood urea nitrogen (BUN), creatinine, and other laboratory test. Also, prenatal and maternal outcome were studied. The data analyzed and compare with each other. Results: Out of 289 patients, 5.9% (17) women had placental abruption, 13.1 % (28) patients had intrauterine growth retardation (IUGR), 32.2% (96) had respiratory distress, and 26.6% (77) of the patients’ infants were transferred to neonatal intensive care unit (NICU). Although the present study showed proteinurea cannot be a sufficient predictor for adverse consequences of preeclampsia, however, the incidence of pregnancy adverse effects increased in the patients with elevated 24-hour proteinuria. Conclusion: The authors concluded that proteinuria in patients with preeclampsia is associated with adverse outcome in pregnancy, although it is not an adequate predictor.